✦ LIBER ✦

Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease

✍ Scribed by Mantzaris, Gerassimos J.; Petraki, Kalliopi; Sfakianakis, Michael; Archavlis, Emmanuel; Christidou, Angeliki; Chadio-Iordanides, Helen; Triadaphyllou, George

Book ID: 122966165
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 273 KB
Volume: 1
Category: Article
ISSN: 1542-3565
DOI: 10.1053/cgh.2003.50015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Budesonide is superior to mesalazine in

Budesonide is superior to mesalazine in maintaining disease remission for patients with steroid-dependent Crohn's disease

✍ G.J. Mantzaris; K. Petraki; E. Chadio; E. Archavlis; A. Christidou; G. Triantafy 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Budesonide is superior to mesalazine in

Budesonide is superior to mesalazine in maintaining disease remission for patients with steroiddependent Crohn's disease

✍ Mantzaris, Gerassimos J.; Petraki, Kalliopi; Archavlis, Emmanuel; Chadio-Iordani 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 178 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, multi-center trial of the engineered human anti body to TNF (CDP571) for steroid sparing and maintenance of remission in patients with steroid-dependent Crohn's disease

✍ Feagan, Brian G.; Sandborn, William J.; Baker, J.P.; Cominelli, F.; Sutherland, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 165 KB